about
Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control StudyA very large protein with diverse functional motifs is deficient in rjs (runty, jerky, sterile) mice.Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.Antibiotic Exposure, Infection, and the Development of Pediatric Psoriasis: A Nested Case-Control Study.Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity.Epidemiology of Clostridium difficile Infection-Associated Reactive Arthritis in Children: An Underdiagnosed, Potentially Morbid Condition.Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.Oral glucocorticoid use and osteonecrosis in children and adults with chronic inflammatory diseases: a population-based cohort studyNav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.Enthesitis is an Extraintestinal Manifestation of Pediatric Inflammatory Bowel Disease.Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulation.Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors.Musculoskeletal MRI findings of juvenile localized sclerodermaComparing record linkage software programs and algorithms using real-world dataTreatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the LiteratureJuvenile Idiopathic Arthritis and the Gut Microbiome: More Clues, More QuestionsEstablishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA WorkshopReview of environmental factors and juvenile idiopathic arthritisIntraarticular Glucocorticoid Injection as Second-line Treatment for Lyme Arthritis in ChildrenPediatric Antibiotic-refractory Lyme Arthritis: A Multicenter Case-control StudyTrends in Cough and Cold Medicine Recommendations for Children in the United States, 2002-2015
P50
Q35701575-5AD276E6-C264-42E9-8B9B-89D096BA82D1Q36260648-FE4BC480-CBA0-458F-B68C-DA2A7988065AQ36266841-D6C56659-970F-4C09-832B-97B8FED30FBDQ36568165-73751AF2-C046-4B68-B4CE-2A32A88AAF46Q37046088-174FAB69-6F1B-4866-99CC-22D86781A156Q37348209-45545C90-A23A-41A0-83BA-0C2346ACF872Q38623183-0904CCFF-B29F-4497-B8AF-0FFD45669048Q38667335-FCC29018-080A-4698-9EF2-E592CFF51E74Q39603773-853FD81D-9149-4AF1-A378-8735D1365841Q39667565-82FCF3FF-1787-4020-86D9-482B58C9A6E4Q40063546-7FF29AE3-E715-4D20-9A5D-80C617B9B658Q42528357-3BCDF65B-6102-44AE-96DE-F774A8AC63F6Q50027874-C0C84FDA-FACF-4D76-9F2B-297D512A33EEQ89941026-9C95C9C9-5DD0-4C5F-9FFD-C5B7BEC208F5Q90255467-E34AB16A-3A3D-4ECF-B4F3-11335C7C24E2Q91049530-01AC81E8-1D5E-4B9C-95F5-79E900C50EF4Q91153155-577EEF2A-AC1A-43DE-BD0C-3FE79BC501ECQ91633732-E952C529-2AFA-45C8-91EF-22FABB73280AQ91738459-C39D2B71-B57D-452D-81EF-A6B709C0C20CQ92061109-5FCC8292-4FB7-4636-99FF-CCB6F49736D1Q92061141-E79CCA58-3D88-45B1-AECD-D0C9B4A6AF39Q92247418-C0E8595B-9A24-4349-ABB0-712F6417FDC7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniel B. Horton
@ast
Daniel B. Horton
@en
Daniel B. Horton
@es
Daniel B. Horton
@sl
type
label
Daniel B. Horton
@ast
Daniel B. Horton
@en
Daniel B. Horton
@es
Daniel B. Horton
@sl
prefLabel
Daniel B. Horton
@ast
Daniel B. Horton
@en
Daniel B. Horton
@es
Daniel B. Horton
@sl
P1053
R-5623-2017
P106
P1153
56745724600
P21
P31
P3829
P496
0000-0002-1831-1339